Phibro Animal Health Stock Today
| PAHC Stock | USD 23.37 0.22 0.93% |
Performance10 of 100
| Odds Of DistressLess than 8
|
Phibro Animal is trading at 23.37 as of the 30th of November 2024, a 0.93% down since the beginning of the trading day. The stock's open price was 23.59. Phibro Animal has only a 8 % chance of going through financial distress over the next few years and had a ok performance during the last 90 days. Equity ratings for Phibro Animal Health are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 3rd of June 2024 and ending today, the 30th of November 2024. Click here to learn more.
Business Domain Pharmaceuticals, Biotechnology & Life Sciences | IPO Date 11th of April 2014 | Category Healthcare | Classification Health Care |
Phibro Animal Health Corporation develops, manufactures, and supplies a range of animal health and mineral nutrition products for food and companion animals. Phibro Animal Health Corporation was founded in 1946 and is headquartered in Teaneck, New Jersey. The company has 20.34 M outstanding shares of which 463.35 K shares are at this time shorted by private and institutional investors with about 2.58 trading days to cover. More on Phibro Animal Health
Moving against Phibro Stock
Follow Valuation Profit Patterns Odds of Bankruptcy
Check how we calculate scores
Phibro Stock Highlights
ESG Sustainability
Environmental | Governance | Social |
| Chairman | Jack Bendheim | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Business Concentration | Pharmaceuticals, Pharmaceuticals, Biotechnology & Life Sciences, Health Care, SP Small-Cap 600, NASDAQ Biotechnology, NASDAQ Composite, NASDAQ Composite Total, NASDAQ Health Care, Health Care, Pharmaceuticals, Drug Manufacturers—Specialty & Generic, Healthcare (View all Sectors) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Average Analyst Recommendation | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Financial Strength
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt LevelsPhibro Animal can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Phibro Animal's financial leverage. It provides some insight into what part of Phibro Animal's total assets is financed by creditors.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Phibro Animal Health (PAHC) is traded on NASDAQ Exchange in USA. It is located in Glenpointe Centre East, Teaneck, NJ, United States, 07666-6712 and employs 1,940 people. Phibro Animal is listed under Pharmaceuticals category by Fama And French industry classification. The company currently falls under 'Small-Cap' category with a current market capitalization of 946.57 M. Phibro Animal Health conducts business under Pharmaceuticals sector and is part of Health Care industry. The entity has 20.34 M outstanding shares of which 463.35 K shares are at this time shorted by private and institutional investors with about 2.58 trading days to cover.
Phibro Animal Health currently holds about 98.67 M in cash with 87.59 M of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.44.
Check Phibro Animal Probability Of Bankruptcy
Ownership AllocationThe majority of Phibro Animal Health outstanding shares are owned by third-party entities. These institutional holders are usually referred to as non-private investors looking to secure positions in Phibro Animal Health to benefit from reduced commissions. Consequently, institutional investors are subject to a different set of regulations than regular investors in Phibro Animal. Please pay attention to any change in the institutional holdings of Phibro Animal Health as this could imply that something significant has changed or is about to change at the company.
Check Phibro Ownership Details
Phibro Stock Institutional Holders
| Instituion | Recorded On | Shares | |
| Castleknight Management Lp | 2024-09-30 | 366.6 K | |
| Nuveen Asset Management, Llc | 2024-06-30 | 346.6 K | |
| Amvescap Plc. | 2024-06-30 | 289.9 K | |
| Charles Schwab Investment Management Inc | 2024-09-30 | 268.4 K | |
| Bank Of New York Mellon Corp | 2024-06-30 | 246.8 K | |
| Sofinnova Ventures | 2024-06-30 | 237 K | |
| Northern Trust Corp | 2024-09-30 | 228.7 K | |
| Goldman Sachs Group Inc | 2024-06-30 | 226.9 K | |
| Globeflex Capital, L.p. | 2024-09-30 | 204.9 K | |
| Blackrock Inc | 2024-06-30 | 3.5 M | |
| Vanguard Group Inc | 2024-09-30 | 1.5 M |
Phibro Animal Historical Income Statement
Phibro Stock Against Markets
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Phibro Animal Health. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate. You can also try the Financial Widgets module to easily integrated Macroaxis content with over 30 different plug-and-play financial widgets.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Phibro Animal. If investors know Phibro will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Phibro Animal listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.94) | Dividend Share 0.48 | Earnings Share 0.43 | Revenue Per Share 25.843 | Quarterly Revenue Growth 0.126 |
The market value of Phibro Animal Health is measured differently than its book value, which is the value of Phibro that is recorded on the company's balance sheet. Investors also form their own opinion of Phibro Animal's value that differs from its market value or its book value, called intrinsic value, which is Phibro Animal's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Phibro Animal's market value can be influenced by many factors that don't directly affect Phibro Animal's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Phibro Animal's value and its price as these two are different measures arrived at by different means. Investors typically determine if Phibro Animal is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Phibro Animal's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.